Longitudinal Neurocognitive Changes for Patients With Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplantation: A Systematic Review With Structured Narrative Synthesis
Open Access
- 7 June 2026
- journal article
- review article
- Published by Wiley in European Journal of Haematology
- Vol. 117 (4) , 814-823
Abstract
Objectives: Neurocognitive changes in hematological malignancies (HM) and as a sequela of hematopoietic stem cell transplantation (HSCT) remain under‐recognized. These changes may substantially affect patients' quality of life. Therefore, this review systematically evaluated longitudinal neurocognitive changes in patients with HM undergoing HSCT. Methods: Following PRISMA guidelines, PubMed, Scopus, and CINAHL were searched on October 30, 2025. Longitudinal studies assessing neurocognitive changes in patients with HM undergoing HSCT, with or without healthy controls, were included. Risk of bias was assessed using an adapted National Institutes of Health quality assessment tool for before–after studies. Effect sizes with 95% confidence intervals were calculated to quantify changes in neurocognitive performance. Results: Nine of 2012 studies met the inclusion criteria, with overall moderate study quality. Improvements may occur post‐HSCT; however, allogeneic HSCT and myeloablative conditioning were main risk factors identified for persistent cognitive decline. In line with white matter damage, executive function and attention/processing speed impairments likely represent core deficits, which may affect other cognitive impairments. Post‐HSCT changes depend on task characteristics, cognitive load, and conditioning intensity. Conclusions: Future research should emphasize regular neurocognitive assessment to guide cognitive rehabilitation, implement pre‐transplant cognitive rehabilitation strategies to mitigate post‐HSCT cognitive decline, and enhance treatment outcomes.Keywords
This publication has 40 references indexed in Scilit:
- Getting too old for this: Population ageing and its economic consequences in FinlandEconomic Analysis and Policy, 2025
- Predictive risk model of mild cognitive impairment in patients with malignant haematological diseases after haematopoietic stem cell transplantationSupportive Care in Cancer, 2025
- Neurocognitive Changes in Spinocerebellar Ataxia Type 3: A Systematic Review with a Narrative DesignThe Cerebellum, 2021
- Neurocognitive Impairment After Hematopoietic Stem Cell Transplant for Hematologic Malignancies: Phenotype and MechanismsThe Oncologist, 2021
- Cognitive rehabilitation for cancer-related cognitive dysfunction: a systematic reviewSupportive Care in Cancer, 2019
- The Role of Age in Neurocognitive Functioning among Adult Allogeneic Hematopoietic Cell Transplant RecipientsTransplantation and Cellular Therapy, 2017
- Return to Work in Mild Cognitive Disorders2016
- A prospective evaluation of changes in brain structure and cognitive functions in adult stem cell transplant recipientsBrain Imaging and Behavior, 2013
- Cognitive functioning in allogeneic hematopoietic stem cell transplantation recipients and its medical correlates: a prospective multicenter studyPsycho-Oncology, 2012
- Mental status changes after hematopoietic stem cell transplantationCancer, 2009